Skip to content

A Post Breastfeeding Follow-Up Study

A Post-Breastfeeding Intervention Observational Follow-Up Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02913638
Enrollment
196
Registered
2016-09-26
Start date
2016-09-30
Completion date
2016-12-31
Last updated
2017-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Feeding

Brief summary

The purpose of this clinical study which is to evaluate the benefits of lactation support intervention, in conjunction with maternal nutritional supplementation during the last trimester to 12 weeks postpartum in comparison to pre- and postnatal care on 1) breast feeding practices (primary objective), and 2) cognitive development in children within 28 months 16 days - 32 months 30 days (secondary objective).

Detailed description

This is an observational study involving mothers and their child at 30 months old as a follow up to the breastfeeding intervention study that they have participated in and completed during the period from the last trimester to 12 weeks postpartum. The assessors will be blinded to subject's treatment group assignment from the intervention phase. There are no products given to any subject. The primary variable is duration of any breastfeeding from birth.

Interventions

None listed

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
28 Months to 32 Months
Healthy volunteers
Yes

Inclusion criteria

* Mother and child pair was enrolled in and completed the breastfeeding intervention (AL08) study. * Age of child is within the allowable window (28 months 16 days - 32 months 30 days). * Subject's parent/Legally Acceptable Representative (LAR) is willing and able to follow study procedures. * Subject's parent/LAR has voluntarily signed and dated an Informed Consent Form (ICF), approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) or other applicable privacy regulation authorization prior to any participation in the study.

Exclusion criteria

* Child has a diagnosis of developmental disorders e.g. cerebral palsy that require medical intervention prior to enrollment in this study.

Design outcomes

Primary

MeasureTime frameDescription
Duration of any breastfeeding from birth32 monthsThe primary variable, which is the duration of any breastfeeding from birth, will be assessed in all mothers recruited for this study. A questionnaire will be used to capture information on the age of the child (in months/weeks) in which the mother stopped breastfeeding. This information will be used to derive any breastfeeding duration from birth onwards.

Secondary

MeasureTime frameDescription
Cognitive outcomes32 monthsBayley Scales (BSID-III) of Infant and Toddler Development
Language/Communication outcomes32 monthsAge & Stages Questionnaire (ASQ-3)

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026